Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits

Virology Journal

Volumn 9, Issue , 2012, Pages

  Meiring, Tracy L ^a   Salimo, Anna T ^a   Coetzee, Beatrix ^c   Maree, Hans J ^c   Moodley, Jennifer ^a   Hitzeroth, Inga I ^a   Freeborough, Michael John ^c   Rybicki, Ed P ^a   Williamson, Anna Lise ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Human immunodeficiency virus; Human papillomavirus; Next generation sequencing; Rolling circle amplification

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; DNA ISOLATION; DNA SEQUENCE; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; SOUTH AFRICA; UTERINE CERVIX; VIRUS IDENTIFICATION; WART VIRUS;

ADULT; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HUMANS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SOUTH AFRICA; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 84864917146     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-164     Document Type: Article

References (28)

1. Worldwide burden of cervical cancer in 2008. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J, Ann Oncol 2011 22 2675 2686 10.1093/annonc/mdr015 21471563
2. Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategies. Allan B, Marais DJ, Hoffman M, Shapiro S, Williamson AL, J Clin Microbiol 2008 46 740 742 10.1128/JCM.01981-07 17977997
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N, J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482
4. Dermatologic manifestations of HPV in HIV-infected individuals. Gormley RH, Kovarik CL, Curr HIV/AIDS Rep 2009 6 130 138 10.1007/s11904-009-0018-8 19589298
5. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM, Virology 2010 401 70 79 10.1016/j.virol.2010.02.002 20206957
6. A review of human carcinogens - Part B: biological agents. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V, Lancet Oncol 2009 10 321 322 10.1016/S1470-2045(09)70096-8 19350698
7. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Lancet Oncol 2010 11 1048 1056 10.1016/S1470-2045(10)70230-8 20952254
8. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, Br J Cancer 2003 88 63 73 10.1038/sj.bjc.6600688 12556961
9. Women with HIV are more commonly infected with non-16 and 18 high-risk HPV types. McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA, Gynecol Oncol 2010 116 572 577 10.1016/j.ygyno.2009.10.058 19906410
10. National Department of Health of South Africa, National Antenatal Sentinel HIV and Syphilis Prevalence Survey in South Africa, 2009.Annual report Pretoria 2010
11. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Firnhaber C, Zungu K, Levin S, Michelow P, Montaner LJ, McPhail P, Williamson AL, Allan BR, Van der Horst C, Rinas A, Sanne I, Acta Cytol 2009 53 10 17 10.1159/000325079 19248549
12. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. Mbulawa ZZ, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL, J Infect Dis 2009 199 1514 1524 10.1086/598220 19392625
13. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. Moodley JR, Constant D, Hoffman M, Salimo A, Allan B, Rybicki E, Hitzeroth I, Williamson AL, BMC Cancer 2009 9 275 10.1186/1471-2407-9-275 19664216
14. Human papillomavirus types among women infected with HIV: a meta-analysis. Clifford GM, Goncalves MA, Franceschi S, AIDS 2006 20 2337 2344 10.1097/01.aids.0000253361.63578.14 17117020
15. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, Van Doorn LJ, J Clin Microbiol 2002 40 3341 3345 10.1128/JCM.40.9.3341-3345.2002 12202576
16. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R, J Natl Cancer Inst 1999 91 226 236 10.1093/jnci/91.3.226 10037100
17. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, JFS P, Petry KU, Kruger Kjaer S, Munk C, Iftner T, J Med Virol 2008 80 1264 1274 10.1002/jmv.21191 18461626
18. Identification of recombinant human papillomavirus type 16 variants. Jiang M, Xi LF, Edelstein ZR, Galloway DA, Olsem GJ, Lin WC, Kiviat NB, Virology 2009 394 8 11 10.1016/j.virol.2009.08.040 19758676
19. Global proficiency study of human papillomavirus genotyping. Eklund C, Zhou T, Dillner J, J Clin Microbiol 2010 48 4147 4155 10.1128/JCM.00918-10 20844222
20. Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Mori S, Nakao S, Kukimoto I, Kusumoto-Matsuo R, Kondo K, Kanda T, Cancer Sci 2011 102 1223 1227 10.1111/j.1349-7006.2011.01922.x 21388488
21. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T, J Clin Microbiol 2010 48 143 149 10.1128/JCM.00991-09 19864475
22. Application of next-generation sequencing technologies in virology. Radford AD, Chapman D, Dixon L, Chantrey J, Darby AC, Hall N, J Gen Virol 2012 30 30
23. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Zerbino DR, Birney E, Genome Res 2008 18 821 829 10.1101/gr.074492.107 18349386
24. The clinical importance of understanding the evolution of papillomaviruses. Bravo IG, de Sanjose S, Gottschling M, Trends Microbiol 2010 18 432 438 10.1016/j.tim.2010.07.008 20739182
25. Human papillomavirus genotyping by 454 next generation sequencing technology. Barzon L, Militello V, Lavezzo E, Franchin E, Peta E, Squarzon L, Trevisan M, Pagni S, Dal Bello F, Toppo S, Palu G, J Clin Virol 2011 52 93 97 10.1016/j.jcv.2011.07.006 21802982
26. TempliPhi, phi29 DNA polymerase based rolling circle amplification of templates for DNA sequencing. Nelson JR, Cai YC, Giesler TL, Farchaus JW, Sundaram ST, Ortiz-Rivera M, Hosta LP, Hewitt PL, Mamone JA, Palaniappan C, Fuller CW, Biotechniques 2002 Suppl 44 47 12083397
27. Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Johne R, Muller H, Rector A, van Ranst M, Stevens H, Trends Microbiol 2009 17 205 211 10.1016/j.tim.2009.02.004 19375325
28. HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAP. Lowe B, Kobayashi L, Lorincz A, Mallonee R, O'Neil D, Thai H, Nazarenko I, J Mol Diagn 2010 12 847 853 10.2353/jmoldx.2010.100045 20847281